Aug 30, 2023 | Dermatology Practice, Pathology Business, Press Release
The leader in digital dermatopathology is recognized in the Health Services category of the prestigious list.
SALT LAKE CITY—August 15, 2023—Today, Inc. named PathologyWatch in the top 7 percent of America’s fastest-growing private companies on the annual Inc. 5000 list. This marks the first appearance on the list for the deep-learning AI company, which focuses on diagnostic and prognostic research for skin cancer.
Founded in 2017, PathologyWatch reached number 386 on the list of 5,000 companies for showcasing a remarkable 1500 percent growth from 2019 to 2022. This achievement makes PathologyWatch the list’s top-ranked health services company based in Utah.
“It’s an incredible honor to have PathologyWatch recognized alongside so many notable companies on the Inc. 500 list,” said Dan Lambert, CEO and cofounder of PathologyWatch. “This acknowledgment is a testament to the perseverance and principles of our entire organization, including AI engineers, dermatopathologists, lab technicians, sales and marketing team, clients and everyone in between. Together, we’ve been able to continue our commitment to combine state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.”
The ongoing prevalence of skin cancer in the United States is a driver in the demand for PathologyWatch’s comprehensive digital dermatopathology solutions. There are over 5 million cases of skin cancer detected every year in America, killing more than two people every hour and making it the country’s most common type of cancer.
Lambert, a melanoma survivor, noted, “This Inc 500 recognition reinforces our mission to preserve and extend life for patients while reducing the cost of healthcare.”
“Running a business has only gotten harder since the end of the pandemic,” said Inc. editor-in-chief Scott Omelianuk. “To make the Inc. 5000 — with the fast growth that it requires — is truly an accomplishment. Inc. is thrilled to honor the companies that are building our future.”
About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.
May 3, 2023 | Dermatology Practice, Press Release
SALT LAKE CITY—May 1, 2023—PathologyWatch, a full-service digital dermatopathology solution, is recognizing May as Melanoma and Skin Cancer Awareness Month with a public awareness campaign of its own.
Many Americans are likely unaware of just how prevalent skin cancer is in the US. In conjunction with Melanoma and Skin Cancer Awareness Month, the Skin Cancer Foundation has released some sobering statistics about the disease:
- With over 5 million cases detected each year in the US, skin cancer is the most common form of cancer.
- More than two people die from skin cancer every hour in the US.
- More people are diagnosed with skin cancer each year in the US than all other cancers combined.
- An estimated 7,990 people will die from melanoma in 2023 (5,420 men and 2,570 women).
- An estimated 186,680 cases of melanoma will be diagnosed in the US in 2023.
- One in five Americans will be diagnosed with skin cancer by the age of 70.
“One other key statistic is that the five-year survival rate for melanoma, when it is detected early, is 99 percent,” said Dan Lambert, CEO of PathologyWatch. “That’s why, during the month of May and beyond, we are encouraging everyone to visit their physician or dermatologist and receive an examination. Our mission at PathologyWatch is to preserve and extend life for patients while reducing the cost of healthcare. Early detection is one way we’re working to achieve that goal.”
PathologyWatch uses cutting-edge technology to connect dermatologists with academic-level dermatopathologists in a workflow utilizing samples shared via digital slides. The full-system digital workflow not only optimizes efficiency but also saves physician time, reduces the burden on office staff, and can help clinics create previously untapped revenue streams.
The Utah-based company will be providing “Show Me Some Skin” T-shirts to dermatologists and dermatopathologists who participate in the upbeat awareness campaign. Dermatologists and dermpaths can receive their free T-shirt by simply registering to join the campaign.
“We feel this is a fun way for dermatologists to help get the word out this month about a serious health issue,” Lambert said. “The most important thing in the fight against skin cancer is for people to take the initiative to get tested. May offers the perfect opportunity to commit to that first step.”
About PathologyWatch
PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.
Apr 25, 2023 | Meet The Team, Pathology Business
PathologyWatch COO Scott Mattivi was honored this month with the Meritorious Achievement Award from Pittsburg State University. The award is the highest honor based on career achievement bestowed by the university’s alumni association.
Mattivi graduated from the university, located in Pittsburg, Kansas, with a bachelor of science degree in biology in 1985 before earning a degree in medical technology from the University of Kansas in 1987.
“No matter where your career path eventually takes you, I think most people retain a soft spot for their alma mater, and that’s certainly the case for me,” says Mattivi. “To be recognized by Pittsburg State is truly an honor. My lifelong interest in science and healthcare was fostered there, and my education and association with Pittsburg State have definitely served me well in my career.”
In May of 2022, Mattivi joined PathologyWatch, which specializes in working with dermatology practices to manage their pathology workflows using a digital model. Mattivi brings strategic leadership and operational oversight to PathologyWatch’s three laboratories, which are located in Salt Lake City, UT, Phoenix, AZ, and Port Charlotte, FL.
Before arriving at PathologyWatch, Mattivi was president of Eurofins-Viracor BioPharma Services, where he worked for more than 13 years. Previous to that, he served as a laboratory manager at Quest Diagnostics for 22 years. Mattivi has earned his Six Sigma Green Belt Certification to ensure the highest quality of processes and services and serves on five different boards in the healthcare industry.
Along the way, Mattivi started programs with clinical lab students at the University of Kansas and Wichita State University to perform molecular science rotations at Viracor. He has been an advocate in sharing the virtues of seeking a career in clinical laboratory sciences with students at multiple regional educational institutions.
In addition to his Pittsburg State award, Mattivi will be honored later this year by the alumni association at the University of Kansas, where he will be recognized on October 6–7 as a distinguished health professions alumnus.
